Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Alopecia areata greatly affects people's life quality, mental health, and work life.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Combination therapies work better than single treatments for hair loss.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

Skin symptoms can indicate endocrine disorders and have various treatments.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

Colorimetry can accurately measure hair growth rates in mice.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.